Clinical Trial Update: OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing OXN PR to OxyPR in chronic osteoarthritis showed non-inferiority for pain and locomotor function with improvement in constipation sympto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• OXN PR (Oxycodone/naloxone prolonged-release)
• OxyPR

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Chronic Osteoarthritis | Phase 3 | Status: COMPLETED